Article Versions Notes

Ssentongo P, Guare EG, Song C, Inoue Y, Sandhu M, Annageldiyev C, Sivik J, Rakszawski K, Naik S, Minagawa K, et al. Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab. Current Oncology. 2026; 33(3):154. https://doi.org/10.3390/curroncol33030154

Ssentongo, Paddy, Emma G. Guare, Chen Song, Yoshitaka Inoue, Manpreet Sandhu, Charyguly Annageldiyev, Jeffrey Sivik, Kevin Rakszawski, Seema Naik, Kentaro Minagawa, and et al. 2026. "Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab" Current Oncology 33, no. 3: 154. https://doi.org/10.3390/curroncol33030154

Ssentongo, P., Guare, E. G., Song, C., Inoue, Y., Sandhu, M., Annageldiyev, C., Sivik, J., Rakszawski, K., Naik, S., Minagawa, K., Mineishi, S., & Paules, C. I. (2026). Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab. Current Oncology, 33(3), 154. https://doi.org/10.3390/curroncol33030154